General
Preferred name
Perzinfotel
Synonyms
EAA-090 ()
P&D ID
PD039852
CAS
144912-63-0
Tags
available
drug candidate
Drug indication
Diabetic neuropathy
Drug Status
investigational
Max Phase
Phase 2
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
7
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugMAP
DrugMatrix
MedChem Express Bioactive Compound Library
ReFrame library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
22
Properties
(calculated by RDKit )
Molecular Weight
260.06
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
3
Rotatable Bonds
3
Ring Count
2
Aromatic Ring Count
1
cLogP
-0.92
TPSA
106.94
Fraction CSP3
0.56
Chiral centers
0.0
Largest ring
7.0
QED
0.48
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
GRIN1, GRIN2A, GRIN2B
iGluR
MOA
glutamate receptor antagonist
Pathway
Membrane Transporter/Ion Channel
Neuronal Signaling
Source data
